Company Overview and News
ChromaDex has a product that can has multiple health benefits, including resistance to weight gain, improved control of blood sugar and cholesterol, reduced nerve damage, and longer lifespan. (79-0)
Ladies and gentlemen, thank you for standing by, and welcome to the ChromaDex Corporation Third Quarter 2017 Earnings Conference Call. My name is Brian, and I will be the conference operator today. [Operator Instructions]. (6-0)
Recent change in company strategy includes sale of their lab business and more focus on Niagen (NR) sales. (147-3)
ChromaDex Corporation (NASDAQ:CDXC) has 48 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 16,945,026 shares. Largest shareholders include Champion River Ventures Ltd, Pioneer Step Holdings Ltd, Frost Phillip Md Et Al, Vanguard Group Inc, and Tieton Capital Management, LLC. (6-0)
* Chromadex Corp - in connection with investment, co agreed to sell 5.6 million shares of common stock at a per share price of $4.10 (6-1)
* Chromadex Corp files for common stock offering by selling stockholders of up to $7.7 million - SEC filing Source text: [bit.ly/2z2cq3P] Further company coverage: (6-0)
* Chromadex Corp says Chromadex expects that Thomas Varvaro will transition from Chromadex over coming months to pursue other opportunities Source text for Eikon: Further company coverage: (6-0)
Ladies and gentlemen thank you for standing by and welcome to the ChromaDex Corporation's Second Quarter 2017 Earnings Conference Call. My name is Vince, and I'll be the conference operator today.
Near-term, investors are looking for progress and updates on new marketing strategy, which could shake up the income statement.
* Chromadex Corp files for resale from time to time of up to 7.65 million shares of co's common stock by the selling stockholders - SEC filing Source text - bit.ly/2rK2K9T Further company coverage:
Ladies and gentlemen thank you for standing by and welcome to the ChromaDex Corporation’s First Quarter 2017 Earnings Conference Call. My name is Karen, and I’ll be the conference operator today.
There were 17 notable investor filings today. CenturyLink Inc (NYSE:CTL) is the largest company of interest. (0-1)
2017-12-11 - Wilton
2017-12-11 - Wilton
2017-12-03 - Wilton
2017-11-27 - Wilton